PureTech Health plc — Investor Relations & Filings
PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| PRTC's Deupirfenidone Granted FDA & EU ODD for IPF | 2026-02-19 | English | |
| PureTech to Present at the JP Morgan Conference | 2026-01-06 | English | |
| 6-K | 2025-12-18 | English | |
| PureTech Appoints Robert Lyne as CEO | 2025-12-18 | English | |
| 6-K | 2025-12-10 | English | |
| Results of AGM on June 16, 2025 – Update Statement | 2025-12-10 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
2 filings
| |||||
| 32599152 | PRTC's Deupirfenidone Granted FDA & EU ODD for IPF | 2026-02-19 | English | ||
| 12186141 | PureTech to Present at the JP Morgan Conference | 2026-01-06 | English | ||
|
2025
13 filings
| |||||
| 13191999 | 6-K | 2025-12-18 | English | ||
| 10361372 | PureTech Appoints Robert Lyne as CEO | 2025-12-18 | English | ||
| 13191996 | 6-K | 2025-12-10 | English | ||
| 9794921 | Results of AGM on June 16, 2025 – Update Statement | 2025-12-10 | English | ||
| 9792817 | Holding(s) in Company | 2025-12-10 | English | ||
| 9608927 | PRTC: Successful FDA Meeting; IPF Phase 3 in 1H26 | 2025-12-08 | English | ||
| 9374494 | PRTC's Gallop: Positive Initial Topline AML Data | 2025-12-05 | English | ||
| 8451354 | Holding(s) in Company | 2025-11-18 | English | ||
| 8138788 | Holding(s) in Company | 2025-11-07 | English | ||
| 8067996 | PRTC: New LYT-200 AML Data + Update at ASH | 2025-11-03 | English | ||
| 8035323 | PRTC: New IPF Data Show Benefit in Older Patients | 2025-10-22 | English | ||
| 8029462 | Holding(s) in Company | 2025-10-17 | English | ||
| 8017522 | Holding(s) in Company | 2025-10-14 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for PureTech Health plc, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
PureTech Health plc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/4932/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=4932 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=4932 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=4932 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 4932}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PureTech Health plc (id: 4932)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.